Nanoparticles carrying paclitaxel and anti-miR-221 for breast cancer therapy triggered by ultrasound

Nanomaterials have been well demonstrated to have the potential to be used for tumor cell-targeted drug delivery. Targeted inhibition of miR-221 was proved to promote the sensitivity of triple genitive breast cancer (TNBC) cells to chemo-drugs. In order to improve the chemotherapeutic effect in TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Libo, Ren, Zhen, Lü, Jinhui, Mo, Xinhai, Lin, Jie, Li, Ya, Ma, Wenjing, Liu, Pengfei, Shen, Yajing, Zhao, Qian, Qian, Lu, Cheng, Xiaoxin, Yu, Zuoren, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427607/
https://www.ncbi.nlm.nih.gov/pubmed/37582832
http://dx.doi.org/10.1038/s41420-023-01594-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427607/
https://www.ncbi.nlm.nih.gov/pubmed/37582832
http://dx.doi.org/10.1038/s41420-023-01594-9

Ejemplares similares